170 related articles for article (PubMed ID: 9044461)
21. Lipid parameters including Lp(a) in hemodialysis patients.
Elisaf M; Bairaktari H; Tzallas C; Germanos N; Koulouridis E; Pappas M; Siamopoulos KC; Tsolas O
Ren Fail; 1994; 16(4):501-9. PubMed ID: 7938758
[TBL] [Abstract][Full Text] [Related]
22. Effects of renal replacement therapy on plasma lipoprotein(a) levels.
Rosas S; Joffe M; Wolfe M; Brayman K; Rader DJ
Am J Nephrol; 2008; 28(3):361-5. PubMed ID: 18057868
[TBL] [Abstract][Full Text] [Related]
23. [Lipoprotein(a) and lipids in chronic renal insufficiency and kidney transplant].
Ochoa-Sosa CA; Mondragón-Rodríguez G; Zamora-González J; Cardoso-Saldaña G; Herrera-Acosta J; Posadas-Romero C
Rev Invest Clin; 1998; 50(4):301-6. PubMed ID: 9830317
[TBL] [Abstract][Full Text] [Related]
24. Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease.
Trenkwalder E; Gruber A; König P; Dieplinger H; Kronenberg F
Kidney Int; 1997 Dec; 52(6):1685-92. PubMed ID: 9407518
[TBL] [Abstract][Full Text] [Related]
25. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure.
Stenvinkel P; Heimbürger O; Tuck CH; Berglund L
Kidney Int; 1998 May; 53(5):1336-42. PubMed ID: 9573549
[TBL] [Abstract][Full Text] [Related]
26. Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival.
Goldwasser P; Michel MA; Collier J; Mittman N; Fein PA; Gusik SA; Avram MM
Am J Kidney Dis; 1993 Jul; 22(1):215-25. PubMed ID: 8322786
[TBL] [Abstract][Full Text] [Related]
27. Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients.
Heimann P; Josephson MA; Fellner SK; Thistlethwaite JR; Stuart FP; Dasgupta A
Am J Nephrol; 1991; 11(6):470-4. PubMed ID: 1840233
[TBL] [Abstract][Full Text] [Related]
28. An increased serum level of free Apo(a) in renal patients is more striking than that of Lp(a) and is influenced by homocysteine.
Herrmann W; Quast S; Ellgass A; Wolter K; Kiessig ST; Molinari E; Riegel W
Nephron; 2000 May; 85(1):41-9. PubMed ID: 10773754
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein(a) levels in patients receiving renal replacement therapy: methodologic issues and clinical implications.
Levine DM; Gordon BR
Am J Kidney Dis; 1995 Jul; 26(1):162-9. PubMed ID: 7611248
[TBL] [Abstract][Full Text] [Related]
30. Does cyclosporin increase lipoprotein(a) concentrations in renal transplant recipients?
Webb AT; Reaveley DA; O'Donnell M; O'Connor B; Seed M; Brown EA
Lancet; 1993 Jan; 341(8840):268-70. PubMed ID: 8093917
[TBL] [Abstract][Full Text] [Related]
31. Lp(a) levels: effects of progressive chronic renal failure and dietary manipulation.
Monzani G; Bergesio F; Ciuti R; Ciciani AM; Martinelli F; Rosati A; Salvadori M
J Nephrol; 1997; 10(1):41-5. PubMed ID: 9241624
[TBL] [Abstract][Full Text] [Related]
32. [Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis].
Takegoshi T; Kitoh C; Shimada T; Kawai K; Yamazaki Y; Mabuchi H
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):757-63. PubMed ID: 8377289
[TBL] [Abstract][Full Text] [Related]
33. Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: influence of apolipoprotein (a) genetic polymorphism.
Auguet T; Sentí M; Rubiés-Prat J; Pelegrí A; Pedro-Botet J; Nogués X; Romero R
Nephrol Dial Transplant; 1993; 8(10):1099-103. PubMed ID: 8272223
[TBL] [Abstract][Full Text] [Related]
34. Renal insufficiency after heart transplantation: a case-control study.
van Gelder T; Balk AH; Zietse R; Hesse C; Mochtar B; Weimar W
Nephrol Dial Transplant; 1998 Sep; 13(9):2322-6. PubMed ID: 9761516
[TBL] [Abstract][Full Text] [Related]
35. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
36. Conventional versus ultrapure dialysate for lowering serum lipoprotein(a) levels in patients on long-term hemodialysis: a randomized trial.
Tao J; Sun Y; Li X; Li H; Liu S; Wen Y; Duan L; Li Y; Li X
Int J Artif Organs; 2010 May; 33(5):290-6. PubMed ID: 20593350
[TBL] [Abstract][Full Text] [Related]
37. [A study of clinical significance of Lp[a] lipoprotein in patients with chronic renal failure treated by hemodialysis].
Takegoshi T; Kitoh C; Yamazaki Y
Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):667-71. PubMed ID: 2145455
[TBL] [Abstract][Full Text] [Related]
38. Lipoprotein(a) in renal disease.
Kronenberg F; Utermann G; Dieplinger H
Am J Kidney Dis; 1996 Jan; 27(1):1-25. PubMed ID: 8546123
[TBL] [Abstract][Full Text] [Related]
39. Apo(a) phenotypes and lp(a) concentrations in renal transplant patients.
Kandoussi AM; Hugue V; Cachera C; Hazzan M; Dracon M; Tacquet A; Noël C
Nephron; 1998 Oct; 80(2):183-7. PubMed ID: 9736817
[TBL] [Abstract][Full Text] [Related]
40. Serum lipoprotein (a) levels in chronic renal failure and liver cirrhosis patients. Relationship with atherosclerosis.
Mady E; Wissa G; Khalifa A; el-Sabbagh M
Dis Markers; 1999 Dec; 15(4):237-47. PubMed ID: 10689547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
